The OPTN Kidney Transplantation Committee intends for both prior and future living donors to receive the same level of priority for a deceased donor organ in the new framework as they receive in the current allocation system.
CPRA >98% signatures must be entered in Waitlist for the candidate to receive additional allocation priority.
Previous use of race-based calculations disadvantaged some Black patients by overestimating their kidney function.
The new formula for Calculated Panel Reactive Antibody (CPRA) will now go into effect on Jan. 26, 2023.
We’ve put together some frequently asked questions to help patients wondering about the upcoming change.
This policy change is intended to more accurately reflect patient sensitization.
